A major clinical trial published in JAMA Pediatrics has found that four widely used classroom accommodations for children with ADHD do not improve classroom behaviour or academic performance. By contrast, structured behavioural supports in the classroom and a moderate dose of stimulant medication substantially reduce rule-breaking, with the medication also boosting assignment completion and quiz scores. The study, led by Professor Gregory A. Fabiano of Florida International University, ran across four summers in the United States and took place within a seven- to eight-week summer treatment programme operated by its Centre for Children and Families.
ADHD is a neurodevelopmental condition marked by ongoing difficulties with sustaining attention, controlling impulses, and managing physical restlessness. In many US schools, roughly half of pupils with ADHD receive formal educational services through individualised education programmes or Section 504 plans, which commonly focus on academic accommodations designed to help students complete the same work as their peers. Typical adjustments include extra time on tasks and quizzes, short breaks, noise-cancelling headphones with desk dividers, and permission to stand while working.
Beyond simple adjustments like noise control or seating, keeping students with ADHD engaged requires more than mitigating distractions. Earlier classroom research suggested that children with ADHD are prone to internal mind-wandering, particularly when rewards are anticipated, and that stimulant medication can lengthen reaction times on attention tasks without boosting productivity in real-world classroom settings.
Clinical guidelines for elementary-aged children with ADHD generally recommend stimulant medications alongside positive behavioural interventions, which emphasise structured expectations, specific praise, daily behaviour goals, and earned privileges. Ordinary teacher reminders have historically offered limited impact, while a 2026 study in a single classroom found that a first‑grader with ADHD stayed focused for only about a minute and a half when prompted by routine verbal reminders, with structured reinforcement extending on-task time.
To test these approaches in a controlled way, Fabiano and colleagues conducted a crossover randomized clinical trial. The design rotated every child through every treatment condition in a randomized, counterbalanced order so that each pupil served as their own comparator. The trial was conducted across four summers from 2022 to 2025 at sites in the southeastern and northeastern United States.
From 306 screened pupils in kindergarten to sixth grade, 280 met diagnostic criteria for ADHD and were enrolled. Of these, 25 did not start the programme, including six whose families expressed concerns about medication or its side effects. Among the 255 who began the intervention, 235 completed it; 20 left early for reasons including pursuing alternative treatments, concerns about medication, scheduling conflicts or a wish not to participate.
The study took place in a structured eight‑week summer treatment programme, adjusted to seven weeks for the fourth cohort due to local calendars. Class sizes ranged from 12 to 15 pupils, with two one‑hour classroom sessions each day before the remaining hours were spent on recreational activities. Each classroom was staffed by a teacher and an aide who underwent a week of intensive training and received daily supervisor feedback, with adherence to prescribed procedures recorded as 97 per cent of seatwork and 94 per cent of lessons.
In the first hour of each day, pupils worked independently on reading, mathematics and language arts. In the second hour, teachers led a whole‑class science or social studies lesson followed by small‑group tasks and a 10‑question multiple‑choice quiz scored from 0 to 100 per cent.
Three treatment factors were systematically varied for every pupil across the summer. Classroom behaviour management alternated in two‑week blocks between a general classroom model and an enhanced behavioural intervention. In the general classroom, staff reviewed rules at the start of class, logged rule violations privately, praised sparingly (one praise statement for every three commands), provided recess irrespective of behaviour, and sent pupils to speak with a supervisor after three aggressive or disrespectful acts.
In the enhanced behavioural classroom, rule violations were recorded on a public point board, and staff delivered three specific praise statements for every command or correction. Pupils also received personalised daily report cards tracking behaviour targets, earned free time for meeting goals, public recognition, and weekly token rewards redeemable for small toys and games.
Stimulant medication was given in one‑week blocks under double‑blind conditions, with mornings administering either a placebo or extended‑release methylphenidate at a moderate dose of 0.3 milligrams per kilogram, averaging about 19 milligrams in total. Academic accommodations rotated randomly each day, cycling through four options in addition to the standard classroom: extended time (50 per cent more time for seatwork and quizzes), frequent breaks (roughly six breaks per hour), adapted seating (standing at desks), and low‑distraction conditions (noise‑cancelling headphones and three‑sided desk dividers).
Daily outcomes included observed rule violations during both class periods, quiz scores, and productivity measured as the rate of correctly completed problems per minute during seatwork. Observers demonstrated moderate‑to‑good reliability in recording rule violations, with an intraclass correlation of 0.71 on a 0–1 scale.
Initial analyses indicated that no two‑way or three‑way interactions between treatments were statistically significant. In short, the academic accommodations did not become effective when paired with behavioural therapy or medication, and medication and behavioural therapy operated independently rather than in combination to produce added benefits.
Across all four accommodations, there was no statistically significant reduction in seatwork rule violations during either class period, nor a significant improvement in quiz scores compared with a standard classroom. In terms of seatwork productivity, every accommodation trended downward, with extended time and low‑distraction workspaces reducing the rate of correct problems per minute by 11 per cent and 4 per cent respectively. Even in unmedicated general classrooms, extended time decreased the average from 1.41 to 1.25 correct problems per minute.
Frequent breaks showed a non‑significant 3 per cent dip, while standing desks produced a similar non‑significant dip after adjustments for multiple testing. The authors conclude that the accommodations produced no benefit and, if anything, may be counterproductive by diverting effort from actual learning. “We were surprised that accommodations did not work alone, or in combination with any of the other treatments,” Fabiano explained. “The results we obtained suggested that these approaches really don’t move the needle with regard to improving classroom functioning in children with ADHD.”
By contrast, enhanced behavioural classroom management and stimulant medication produced substantial behavioural gains. During independent seatwork, rule violations fell from 5.74 per hour in the unmedicated general classroom to 3.96 with behavioural support alone, 2.75 with medication alone, and 1.27 when both were used. The behavioural intervention reduced expected seatwork violations by 37 per cent, while medication achieved a 61 per cent reduction relative to placebo, with similar improvements during the group lesson hour.
Medication also improved productivity, boosting the rate of correct problems per minute by 22 per cent relative to placebo, from 1.41 to 1.62. The behavioural classroom intervention produced a smaller but statistically significant 3 per cent increase. On the daily science and social studies quizzes, medication raised scores by about 3.9 percentage points (roughly from 66 per cent to 70 per cent), while the effect of behavioural therapy on quiz scores did not reach significance.
Fabiano characterised the practical implications: “Practically, the accommodations had no effect, or at times a slightly negative effect, on performance in the classroom. Positive behaviour supports and medications improved behaviour, and medication improved completion of independent work. Medication improved quiz scores as well, but only by an average of 3–4 points.”
The authors note that the gains in the classroom occurred at a moderate stimulant dose, with very few side‑effects leading to stopping the medication; four children withdrew during the trial and six withdrew before the start due to medication or side‑effect concerns. They also highlight that guidelines often push for higher doses, yet the study suggests a moderate dose may suffice for many children with ADHD, while the behavioural tools tested required no additional staff time or cost.
“Even though academic accommodations such as extra time are among the most commonly recommended approaches for a child with ADHD, there was no evidence in our study that they worked,” Fabiano observed. “Stimulant medication improved academic productivity and quiz scores, consistent with many other studies. Both medication and positive behaviour supports promoted rule‑following. Because schools do not prescribe medication, our results suggest they should direct much more effort toward providing positive behaviour supports.”
There are caveats to consider. Fabiano disclosed receiving book royalties during the study from Guilford Press, which publishes his manual on daily behaviour report cards, a core component of the behavioural classroom intervention. The study was conducted in a seven‑ to eight‑week summer programme with intensively trained staff, rather than across a full school year, and medication was tested in week‑long blocks rather than over months.
Individual students varied in their use of accommodations, and ongoing analyses are examining whether specific accommodations remain beneficial for certain cognitive profiles. The authors caution that the results may not generalise to typical school settings, given the highly structured summer environment, and they emphasise replication in ordinary classrooms.
Looking ahead, the research team plans to study how schools can incorporate effective behavioural tools into wider Multi‑Tiered Systems of Support, a widely used framework for student help. Fabiano added: “We urgently need to better support students with ADHD. Next steps include partnering with schools to embed positive behavioural supports within these frameworks, and considering reductions in lengthy assessments if the goal is mainly to determine academic accommodations, which did not appear to improve behaviour.”
The study, “Attention‑Deficit/Hyperactivity Disorder Accommodations, Behavior Therapy, and Stimulant Medication: A Randomized Clinical Trial,” was authored by Gregory A. Fabiano, Brittany M. Merrill, Rosalia F. Gallo, Marcela Ramos, Morgan Jusko, Devon Tower, Elizabeth M. Gnagy, Amy Boeckel, Jennifer Piscitello, Maya Renaud, Alyssa Dawson, Jennifer Sikov, Carolina Ramirez, Grant C. Edmondson, Michael S. Adragna, Carlos A. Salgado, and Timothy B. Hayes.